ROIV
Roivant Sciences Ltd.
Stock
$35.72+0.22 (+0.62%)Close Oct 2, 2026
- Operating income, FY2025
- −$515M
Operating income
Operating income by fiscal year
| Period | Operating income | YoY |
|---|---|---|
| FY2025 | −$515M | — |
| FY2024 | −$1.0B | — |
| FY2023 | $4.5B | — |
| FY2022 | −$907M | — |
| FY2021 | −$1.4B | — |
| FY2020 | −$1.1B | — |